<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">psychiatry</journal-id><journal-title-group><journal-title xml:lang="ru">ПСИХИАТРИЯ</journal-title><trans-title-group xml:lang="en"><trans-title>Psychiatry (Moscow) (Psikhiatriya)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1683-8319</issn><issn pub-type="epub">2618-6667</issn><publisher><publisher-name>FSBSI “The Mental Health Research Centre”;   LLC «Publisher «MIA»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/2618-6667-2023-21-1-27-33</article-id><article-id custom-type="elpub" pub-id-type="custom">psychiatry-916</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПСИХОПАТОЛОГИЯ, КЛИНИЧЕСКАЯ И БИОЛОГИЧЕСКАЯ ПСИХИАТРИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PSYCHOPATHOLOGY, CLINICAL AND BIOLOGICAL PSYCHIATRY</subject></subj-group></article-categories><title-group><article-title>Нарушения мышления у депрессивных больных юношеского возраста из группы риска манифестации шизофрении</article-title><trans-title-group xml:lang="en"><trans-title>Thought Disorders in Depressive Adolescents with High-Risk for  Schizophrenia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8343-168X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Омельченко</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Omelchenko</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мария Анатольевна Омельченко, доктор медицинских наук, заведующий отделом по подготовке специалистов в области психиатрии</p><p>Москва</p></bio><bio xml:lang="en"><p>Maria A. Omelchenko, Dr. of Sci. (Med.), Head of Department, Department of Psychiatrist Education</p><p>Moscow</p></bio><email xlink:type="simple">omelchenko-ma@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4374-2798</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Арутюнова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Arutyunova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елизавета Валерьевна Арутюнова, ординатор</p><p>Москва</p></bio><bio xml:lang="en"><p>Elizaveta V. Arutyunova, Resident</p><p>Moscow</p></bio><email xlink:type="simple">elizavetaarutyunova01@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научный центр психического здоровья»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBSI “Mental Health Research Centre”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>МГУ им. М.В. Ломоносова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>03</day><month>03</month><year>2023</year></pub-date><volume>21</volume><issue>1</issue><fpage>27</fpage><lpage>33</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Омельченко М.А., Арутюнова Е.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Омельченко М.А., Арутюнова Е.В.</copyright-holder><copyright-holder xml:lang="en">Omelchenko M.A., Arutyunova E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.journalpsychiatry.com/jour/article/view/916">https://www.journalpsychiatry.com/jour/article/view/916</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование: необходимость разработки методов ранней диагностики и превентивных вмешательств у лиц из группы риска манифестации шизофрении требует изучения особенностей проявлений преддебютных стадий. Такими симптомами 27 могут быть нарушения мышления, занимающие неоднозначное положение в психопатологической структуре шизофрении.</p></sec><sec><title>Цель</title><p>Цель: провести корреляционный анализ нарушений мышления у больных юношеского возраста с аттенуированными симптомами шизофрении (АСШ) в первом депрессивном эпизоде.</p></sec><sec><title>Пациенты и методы</title><p>Пациенты и методы: в исследование включены 30 юношей (средний возраст 19,2 ± 2,1 года), впервые госпитализированных в состоянии депрессии (F32.1, F32.2, F32.28, F32.8 по МКБ10), в структуре которой отмечались АСШ. Выраженность нарушений мышления определялась по шкале оценки мышления, речи и коммуникации (Thought, Language and Communication Scale, TLC) перед выпиской. Изучены корреляции суммарного балла по шкале TLC и таких характеристик, как длительность текущего депрессивного эпизода, степень тяжести депрессии по шкале Гамильтона (HDRS), выраженность АСШ по шкалам оценки продромальных симптомов (Scale of Prodromal Symptoms, SOPS) и негативных симптомов (Scale for Assessment of Negative Symptoms, SANS), дозы психофармакологических препаратов.</p></sec><sec><title>Результаты</title><p>Результаты: медианное значение суммарного балла по шкале TLC составило 20 [17,3; 23,5]. Обнаружены лишь незначительные взаимосвязи нарушений мышления с депрессивным аффектом и АСШ. Суммарный балл по шкале TLC коррелировал только с оценкой по шкале SOPS при поступлении (r = 0,370, p &lt; 0,05), что отражает связь нарушений мышления с активностью эндогенного процесса на ранних его этапах. Корреляция TLC с подшкалой «Нарушение внимания» SANS при выписке (r = 0,388, p &lt; 0,05) также косвенно отражает наличие нарушения мышления. Наибольшее количество корреляций продемонстрировал параметр «Непоследовательность» шкалы TLC.</p></sec><sec><title>Заключение</title><p>Заключение: полученные данные свидетельствуют о независимом характере нарушений мышления у пациентов юношеского возраста с первым эпизодом депрессии, что указывает на необходимость определения их самостоятельного прогностического значения для риска манифестации шизофрении.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background: the need to develop methods for early diagnostics and preventive interventions in individuals at clinical high-risk state for schizophrenia requires studying the characteristics of the specific symptoms of pre-onset stages. One of such symptoms may be thought disorder, which still have an ambiguous position in the psychopathological structure of schizophrenia.</p></sec><sec><title>Aim</title><p>Aim: correlation analysis of thought disorders in patients with first depressive episode with attenuated symptoms of schizophrenia (ASS).</p></sec><sec><title>Patients and methods</title><p>Patients and methods: the study included 30 young men (mean age 19.2 ± 2.1 years) hospitalized with the first depressive episode (F32.1, F32.2, F32.28, F32.8 on ICD-10), in the structure of which ASS were noted. The severity of thought disorders was assessed using the Thought, Language and Communication scale (TLC) before discharge. Subsequently was performed the search for correlations of scores on the TLC and other characteristics as duration of the current depressive episode, severity of depressive symptoms according to the Hamilton Depression Rating Scale (HDRS), the severity of ASS according to Scale of Prodromal Symptoms (SOPS) and Scale for Assessment of Negative Symptoms (SANS), drug therapy doses.</p></sec><sec><title>Results</title><p>Results: the median value of the total score on the TLC was 20 [17.3;23.5]. The most important finding is the discovery of only weak correlations of thought disorders with depressive affect and ASS. Indeed, the total score on the TLC correlated only with the total score on the SOPS at admission (r = 0.370, p &lt; 0.05), which refiects the relationship between the thought disorders and the activity of endogenous process in the early stages, and with the SANS subscale “Attention” at discharge (r = 0.388, p &lt; 0.05), which also indirectly refiects the existing thought disorders. The greatest number of correlations was demonstrated by the TLC parameter “Illogicality”.</p></sec><sec><title>Conclusion</title><p>Conclusion: the data obtained indicates the independent nature of thought disorders in youth patients with first-onset of depression, which indicates the need to determine its independent prognostic value for schizophrenia manifestation.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>нарушения мышления</kwd><kwd>юношеские депрессии</kwd><kwd>группа риска</kwd><kwd>шизофрения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>thought disorder</kwd><kwd>adolescent depression</kwd><kwd>high-risk</kwd><kwd>schizophrenia</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">исследование поддержано грантом РНФ № 22-15-00437 «Мультимодальные подходы к оценке риска и профилактике манифестации психозов шизофренического спектра в юношеском возрасте».</funding-statement><funding-statement xml:lang="en">the study was supported by RSF #22-15-00437 “Multimodal approaches to risk assessment and prevention of manifestation of schizophrenic spectrum psychoses in young adults”.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Legge SE, Cardno AG, Allardyce J, Dennison C, Hubbard L, Pardiñas AF, Richards A, Rees E, Di Florio A, Escott-Price V, Zammit S, Holmans P, Owen MJ, O’Donovan MC, Walters J. Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia. JAMA Psychiatry. 2021;78(10):1143–1151. doi: 10.1001/jamapsychiatry.2021.1961</mixed-citation><mixed-citation xml:lang="en">Legge SE, Cardno AG, Allardyce J, Dennison C, Hubbard L, Pardiñas AF, Richards A, Rees E, Di Florio A, Escott-Price V, Zammit S, Holmans P, Owen MJ, O’Donovan MC, Walters J. Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia. JAMA Psychiatry. 2021;78(10):1143–1151. doi: 10.1001/jamapsychiatry.2021.1961</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Клюшник ТП, Смулевич АБ, Зозуля СА, Воронова ЕИ. Нейробиология шизофрении и клинико-психопатологические корреляты (к построению клинико-биологической модели). Психиатрия. 2021;19(1):6–15.</mixed-citation><mixed-citation xml:lang="en">Klyushnik TP, Smulevich AB, Zozulya SA, Voronova EI. Neurobiology of Schizophrenia (to the Construction of Clinical and Biological Model). Psychiatry (Moscow) (Psikhiatriya). 2021;19(1):6–15. (In Russ.). doi: 10.30629/2618-6667-2021-19-1-6-15</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenman S, Korten A, Medway J, Evans M. Dimensional vs. categorical diagnosis in psychosis. Acta Psychiatr Scand. 2003;107(5):378–384. doi: 10.1034/j.1600-0447.2003.00059.x</mixed-citation><mixed-citation xml:lang="en">Rosenman S, Korten A, Medway J, Evans M. Dimensional vs. categorical diagnosis in psychosis. Acta Psychiatr Scand. 2003;107(5):378–384. doi: 10.1034/j.1600-0447.2003.00059.x</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hart M, Lewine RRJ. Rethinking Thought Disorder. Schizophr Bull. 2017;43(3):514–522. doi: 10.1093/schbul/sbx003</mixed-citation><mixed-citation xml:lang="en">Hart M, Lewine RRJ. Rethinking Thought Disorder. Schizophr Bull. 2017;43(3):514–522. doi: 10.1093/schbul/sbx003</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Fusar-Poli P. The Clinical High-Risk State for Psychosis (CHR-P), Version II. Schizophr Bull. 2017;43(1):44–47. doi: 10.1093/schbul/sbw158</mixed-citation><mixed-citation xml:lang="en">Fusar-Poli P. The Clinical High-Risk State for Psychosis (CHR-P), Version II. Schizophr Bull. 2017;43(1):44–47. doi: 10.1093/schbul/sbw158</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Solmi M, Radua J, Olivola M, Croce E, Soardo L, de Pablo GS, Il Shin J, Kirkbride JB, Jones P, Kim JH, Kim JY, Carvalho AF, Seeman MV, Correll CU, Fusar-Poli P. Age at onset of mental disorders worldwide: largescale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27(1):281–295. doi: 10.1038/s41380-021-01161-7</mixed-citation><mixed-citation xml:lang="en">Solmi M, Radua J, Olivola M, Croce E, Soardo L, de Pablo GS, Il Shin J, Kirkbride JB, Jones P, Kim JH, Kim JY, Carvalho AF, Seeman MV, Correll CU, Fusar-Poli P. Age at onset of mental disorders worldwide: largescale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27(1):281–295. doi: 10.1038/s41380-021-01161-7</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Li R, Ma X, Wang G, Yang J, Wang C. Why sex differences in schizophrenia? J Transl Neurosci (Beijing). 2016;1(1):37–42. PMID: 29152382; PMCID: PMC5688947.</mixed-citation><mixed-citation xml:lang="en">Li R, Ma X, Wang G, Yang J, Wang C. Why sex differences in schizophrenia? J Transl Neurosci (Beijing). 2016;1(1):37–42. PMID: 29152382; PMCID: PMC5688947.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Омельченко МА. Клинико-психопатологические особенности юношеских депрессий с аттенуированными симптомами шизофренического спектра. Психиатрия. 2021;19(1):16–25. doi: 10.30629/26186667-2021-19-1-16-25</mixed-citation><mixed-citation xml:lang="en">Omelchenko MA. Clinical Features of Youth Depression with Attenuated Symptoms of the Schizophrenic Spectrum. Psychiatry (Moscow) (Psikhiatriya). 2021;19(1):16–25. (In Russ.). doi: 10.30629/2618-6667-2021-19-1-16-25</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Marín O. Developmental timing and critical windows for the treatment of psychiatric disorders. Nat Med. 2016;22(11):1229–1238. doi: 10.1038/nm.4225</mixed-citation><mixed-citation xml:lang="en">Marín O. Developmental timing and critical windows for the treatment of psychiatric disorders. Nat Med. 2016;22(11):1229–1238. doi: 10.1038/nm.4225</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Malla A, Joober R, Iyer S, Norman R, Schmitz N, Brown T, Lutgens D, Jarvis E, Margolese HC, Casacalenda N, Abdel-Baki A, Latimer E, Mustafa S, Abadi S. Comparing three-year extension of early intervention service to regular care following two years of early intervention service in  rst-episode psychosis: a randomized single blind clinical trial. World Psychiatry. 2017;16(3):278–286. doi: 10.1002/wps.20456</mixed-citation><mixed-citation xml:lang="en">Malla A, Joober R, Iyer S, Norman R, Schmitz N, Brown T, Lutgens D, Jarvis E, Margolese HC, Casacalenda N, Abdel-Baki A, Latimer E, Mustafa S, Abadi S. Comparing three-year extension of early intervention service to regular care following two years of early intervention service in  rst-episode psychosis: a randomized single blind clinical trial. World Psychiatry. 2017;16(3):278–286. doi: 10.1002/wps.20456</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lewandowski KE, Bouix S, Ongur D, Shenton ME. Neuroprogression across the Early Course of Psychosis. J Psychiatr Brain Sci. 2020;5:e200002. doi: 10.20900/jpbs.20200002</mixed-citation><mixed-citation xml:lang="en">Lewandowski KE, Bouix S, Ongur D, Shenton ME. Neuroprogression across the Early Course of Psychosis. J Psychiatr Brain Sci. 2020;5:e200002. doi: 10.20900/jpbs.20200002</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:5662. doi: 10.1136/jnnp.23.1.56</mixed-citation><mixed-citation xml:lang="en">Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:5662. doi: 10.1136/jnnp.23.1.56</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703–715. doi: 10.1093/oxfordjournals.schbul.a007040</mixed-citation><mixed-citation xml:lang="en">Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703–715. doi: 10.1093/oxfordjournals.schbul.a007040</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry. Suppl. 1989;(7):49–58. PMID: 2695141.</mixed-citation><mixed-citation xml:lang="en">Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry. Suppl. 1989;(7):49–58. PMID: 2695141.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Andreasen NC. Scale for the assessment of thought, language, and communication (TLC). Schizophr Bull. 1986;12(3):473–482. doi: 10.1093/schbul/12.3.473</mixed-citation><mixed-citation xml:lang="en">Andreasen NC. Scale for the assessment of thought, language, and communication (TLC). Schizophr Bull. 1986;12(3):473–482. doi: 10.1093/schbul/12.3.473</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Arndt S, Alliger RJ, Andreasen NC. The distinction of positive and negative symptoms. The failure of a two-dimensional model. Br J Psychiatry. 1991;158:317–322. doi: 10.1192/bjp.158.3.317</mixed-citation><mixed-citation xml:lang="en">Arndt S, Alliger RJ, Andreasen NC. The distinction of positive and negative symptoms. The failure of a two-dimensional model. Br J Psychiatry. 1991;158:317–322. doi: 10.1192/bjp.158.3.317</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Carbon M, Correll CU. Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia. CNS Spectr. 2014;19(1):35–37. doi: 10.1017/S1092852914000601</mixed-citation><mixed-citation xml:lang="en">Carbon M, Correll CU. Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia. CNS Spectr. 2014;19(1):35–37. doi: 10.1017/S1092852914000601</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkötter J, McGuire P, Yung A. The Psychosis High-Risk State: A Comprehensive State-of-theArt Review. JAMA Psychiatry. 2013;70(1):107–120. doi: 10.1001/jamapsychiatry.2013.269</mixed-citation><mixed-citation xml:lang="en">Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkötter J, McGuire P, Yung A. The Psychosis High-Risk State: A Comprehensive State-of-theArt Review. JAMA Psychiatry. 2013;70(1):107–120. doi: 10.1001/jamapsychiatry.2013.269</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Смулевич АБ, Клюшник ТП, Борисова ПО, Лобанова ВМ, Воронова ЕИ. Кататония (актуальные проблемы психопатологии и клинической систематики). Психиатрия. 2022;20(1):6–16. doi: 10.30629/26186667-2022-20-1-6-16</mixed-citation><mixed-citation xml:lang="en">Smulevich AB, Klyushnik TP, Borisova PO, Lobanova VM, Voronova EI. Catatonia (Actual Problems of Psychopatology and Clinical Systematics). Psychiatry (Moscow) (Psikhiatriya). 2022;20(1):6–16. (In Russ.). doi: 10.30629/2618-6667-2022-20-16-16</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
